1. Home
  2. RLAY vs AHCO Comparison

RLAY vs AHCO Comparison

Compare RLAY & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$9.59

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo AdaptHealth Corp.

AHCO

AdaptHealth Corp.

HOLD

Current Price

$11.12

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
AHCO
Founded
2015
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
RLAY
AHCO
Price
$9.59
$11.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
4
Target Price
$16.86
$13.25
AVG Volume (30 Days)
2.5M
1.4M
Earning Date
05-04-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
31.78
N/A
EPS
N/A
N/A
Revenue
$15,355,000.00
$3,244,857,000.00
Revenue This Year
N/A
$9.00
Revenue Next Year
$324.03
$6.93
P/E Ratio
N/A
N/A
Revenue Growth
53.44
N/A
52 Week Low
$1.78
$7.11
52 Week High
$11.49
$11.75

Technical Indicators

Market Signals
Indicator
RLAY
AHCO
Relative Strength Index (RSI) 49.08 61.06
Support Level $9.06 $8.69
Resistance Level $11.46 N/A
Average True Range (ATR) 0.63 0.48
MACD -0.12 0.16
Stochastic Oscillator 16.18 71.36

Price Performance

Historical Comparison
RLAY
AHCO

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About AHCO AdaptHealth Corp.

AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.

Share on Social Networks: